(Q30767606)

26 June 2017

title

Selective A1-adenosine receptor antagonists identified using yeast Saccharomyces cerevisiae functional assays (English)

1 reference

26 June 2017

main subject

Saccharomyces cerevisiae

0 references

author name string

Campbell RM

1

1 reference

26 June 2017

Cartwright C

2

1 reference

26 June 2017

Chen W

3

1 reference

26 June 2017

Chen Y

4

1 reference

26 June 2017

Duzic E

5

1 reference

26 June 2017

Fu JM

6

1 reference

26 June 2017

Loveland M

7

1 reference

26 June 2017

Manning R

8

1 reference

26 June 2017

McKibben B

9

1 reference

26 June 2017

Pleiman CM

10

1 reference

26 June 2017

Silverman L

11

1 reference

26 June 2017

Trueheart J

12

1 reference

26 June 2017

Webb DR

13

1 reference

26 June 2017

Wilkinson V

14

1 reference

26 June 2017

Witter DJ

15

1 reference

26 June 2017

Xie X

16

1 reference

26 June 2017

Castelhano AL

17

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

26 June 2017

number of pages

6

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

26 June 2017

volume

9

1 reference

26 June 2017

issue

16

1 reference

26 June 2017

page(s)

2413-2418

1 reference

New assay technologies for high-throughput screening

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

Adenosine receptors: new opportunities for future drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

N6-cyclopentyl-3'-substituted-xylofuranosyladenosines: a new class of non-xanthine adenosine A1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

DNA antisense therapy for asthma in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900398-4

7 January 2021

10.1016/S0960-894X(99)00398-4

Identifiers

DOI

1 reference

26 June 2017

1 reference